Optimi Health to Present at the ThinkEquity Conference
Key Highlights
- ➤Optimi Health (OPTH) will present a corporate overview at the ThinkEquity Conference October 15.
- ➤Optimi management will hold one-on-one investor meetings at the New York City conference.
- ➤Optimi manufactures GMP-grade MDMA and botanical psilocybin products in British Columbia.
- ➤Optimi products are prescribed in Australia and accessible in Canada through regulatory programs.
VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (FSE: 8BN) (“Optimi” or “the Company”), a commercial-stage pharmaceutical manufacturer and clinical-stage developer of regulated psychedelic drug products, today announced that it will participate in the ThinkEquity Conference taking place on October 15, 2026, at the Mandarin Oriental Hotel in New York City. Management will present a corporate overview at 4:00 p.m. Eastern time and will be available for one-on-one meetings with investors registered for the event.
Investors interested in scheduling a meeting with Optimi management should contact their ThinkEquity representative or register for the conference here.
Get started
Create a free account to read the full story.